Janssen CarePath provides the additional support you may need to help you get started with DARZALEX® treatment, once your doctor has prescribed it for you. You can call a Janssen CarePath Coordinator at 877-CarePath (877-227-3728) or set up a personal Janssen CarePath Account by clicking here.
Your personally assigned Janssen CarePath Care Coordinator can:
- Review your health plan benefits to help answer questions you may have about insurance coverage for DARZALEX®
- Identify options that may help make DARZALEX® more affordable, if needed
- Provide transportation assistance information and referral to independent organizations that may provide assistance with costs associated with travel to and from treatment
- Offer treatment education resources such as the DARZALEX® Comfort Kit
- Connect you with a clinical nurse to answer questions about your disease and treatment with DARZALEX®*
*The DARZALEX® nurse program is not intended to provide medical advice, replace your treatment plan with your doctor or nurse, or provide treatment or case management services. You should always talk to your healthcare provider and treatment team about any medical decisions and concerns you may have.
If you have any questions, please call Janssen CarePath at 844-55DARZA (844-553-2792) Monday through Friday 8 AM to 8 PM ET.
Get started with a Janssen CarePath Account
Sign Up or Log In to your personal Janssen CarePath Account so you can learn about your insurance coverage for DARZALEX® and find support to help you stay on track with your Janssen medication. Within your account you can:
- Link your account to your prescriber
- Request a benefits investigation
- See the results of your benefits investigation to understand your insurance coverage
- Learn about treatment support programs
Learn more about your DARZALEX® treatment at Darzalex.com.
Help if Your Insurance Plan Does Not Approve DARZALEX® Treatment
Sometimes you may not be able to obtain the medication that your doctor has ordered for you. For example, your insurance plan might not cover the medication because it is not on the plan’s drug list (formulary) or the cost is higher than you think you should have to pay. In these situations, you and your doctor have the right to ask the insurance plan to explain its decision and to consider making the medication available to you as an exception to its policies.
Click here for the guide “How to Request an Exception or Appeal a Decision From Your Prescription Drug Plan.”
DARZALEX® is a prescription medicine used to treat multiple myeloma:
- In combination with the medicines lenalidomide and dexamethasone or bortezomib and dexamethasone, in people who have received at least one prior medicine to treat multiple myeloma.
- In combination with the medicines pomalidomide and dexamethasone in people who have received at least two prior medicines to treat multiple myeloma, including lenalidomide and a proteasome inhibitor.
- Alone in people who have received at least three prior medicines to treat multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or did not respond to a proteasome inhibitor and an immunomodulatory agent.
It is not known if DARZALEX® is safe and effective in children.
What should I tell my healthcare provider before taking DARZALEX®?
Before you receive DARZALEX®, tell your healthcare provider about all of your medical conditions, including if you:
- have a history of breathing problems
- have had shingles (herpes zoster)
are pregnant or plan to become pregnant. DARZALEX® may harm your unborn baby.
- Females who are able to become pregnant should use an effective method of birth control during treatment and for at least 3 months after your final dose of DARZALEX®. Talk to your healthcare provider about birth control methods that you can use during this time.
- are breastfeeding or plan to breastfeed. It is not known if DARZALEX® passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will I receive DARZALEX®?
- DARZALEX® may be given alone or together with other medicines used to treat multiple myeloma.
- DARZALEX® will be given to you by intravenous (IV) infusion into your vein.
- Your healthcare provider will decide the time between doses as well as how many treatments you will receive.
- Your healthcare provider will give you medicines before each dose of DARZALEX® and on the first day after each dose of DARZALEX® to help reduce the risk of infusion reactions.
- If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment
What are the possible side effects of DARZALEX®?
DARZALEX® may cause serious reactions, including:
Infusion reactions. Infusion reactions are common with DARZALEX® and can be severe. Your healthcare provider may temporarily stop your infusion or completely stop treatment with DARZALEX® if you have infusion reactions. Tell your healthcare provider right away if you get any of the following symptoms:
- shortness of breath or trouble breathing
- dizziness or lightheadedness (hypotension)
- throat tightness
- runny or stuffy nose
- Changes in blood tests. DARZALEX® can affect the results of blood tests to match your blood type. These changes can last for up to 6 months after your final dose of DARZALEX®. Your healthcare provider will do blood tests to match your blood type before you start treatment with DARZALEX®. Tell all of your healthcare providers that you are being treated with DARZALEX® before receiving blood transfusions.
- Decreases in blood cell counts. DARZALEX® can decrease white blood cell counts which help fight infections and blood cells called platelets which help to clot blood. Tell your healthcare provider if you develop fever or have signs of bruising or bleeding.
The most common side effects of DARZALEX® include:
- muscle spasms
- joint pain
- back pain
- shortness of breath
- swollen hands, ankles or feet
- nerve damage causing tingling, numbness or pain
- cold-like symptoms (upper respiratory infection)
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of DARZALEX®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information about the safe and effective use of DARZALEX®
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about DARZALEX® that is written for health professionals.
Please see Important Product Information